Cargando…

Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues

Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with long...

Descripción completa

Detalles Bibliográficos
Autores principales: Raja, Umar Y, Eastaugh, Alison E, Younas, Mohammed S, Hanif, Wasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359167/
https://www.ncbi.nlm.nih.gov/pubmed/26668738
http://dx.doi.org/10.1177/2048004015576008
_version_ 1782361353697099776
author Raja, Umar Y
Eastaugh, Alison E
Younas, Mohammed S
Hanif, Wasim
author_facet Raja, Umar Y
Eastaugh, Alison E
Younas, Mohammed S
Hanif, Wasim
author_sort Raja, Umar Y
collection PubMed
description Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with longstanding insulin-dependent diabetes started on a GLP-1 analogue, liraglutide, who now has controlled blood sugars without the need of insulin.
format Online
Article
Text
id pubmed-4359167
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-43591672015-12-14 Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues Raja, Umar Y Eastaugh, Alison E Younas, Mohammed S Hanif, Wasim JRSM Cardiovasc Dis Case Report Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with longstanding insulin-dependent diabetes started on a GLP-1 analogue, liraglutide, who now has controlled blood sugars without the need of insulin. SAGE Publications 2015-03-11 /pmc/articles/PMC4359167/ /pubmed/26668738 http://dx.doi.org/10.1177/2048004015576008 Text en © The European Society of Cardiology 2015 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Raja, Umar Y
Eastaugh, Alison E
Younas, Mohammed S
Hanif, Wasim
Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
title Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
title_full Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
title_fullStr Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
title_full_unstemmed Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
title_short Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
title_sort longstanding insulin dependent diabetics may not require insulin after the introduction of glp-1 analogues
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359167/
https://www.ncbi.nlm.nih.gov/pubmed/26668738
http://dx.doi.org/10.1177/2048004015576008
work_keys_str_mv AT rajaumary longstandinginsulindependentdiabeticsmaynotrequireinsulinaftertheintroductionofglp1analogues
AT eastaughalisone longstandinginsulindependentdiabeticsmaynotrequireinsulinaftertheintroductionofglp1analogues
AT younasmohammeds longstandinginsulindependentdiabeticsmaynotrequireinsulinaftertheintroductionofglp1analogues
AT hanifwasim longstandinginsulindependentdiabeticsmaynotrequireinsulinaftertheintroductionofglp1analogues